Drugs / Protamin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02452307 | Apr 2004 → Oct 2017 | prostate carcinoma | University Hospital Tuebingen | Unknown | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT02675647 Background | Dec 2015 → Dec 2016 | morbid obesity | University Hospital, Strasbourg, France | Completed | No outcome recorded |
| — | NCT06154018 Comparator | Mar 2023 → Apr 2024 | blood coagulation disease, cardiac valvular defect, heart valve disorder | University of Ioannina | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Protamin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06154018 ↗ |
| Route | Subcutaneous | “subcutaneous” NCT02452307 ↗ |